What is Dow Development Laboratories?
Dow Development Laboratories operates as a specialized contract development and manufacturing organization (CDMO) headquartered in Northern California. The firm provides an essential suite of services, including formulation development, analytical method validation, and clinical packaging, specifically tailored for the pharmaceutical and biotechnology industries. As an FDA-registered and cGMP-compliant entity, the company serves as a vital partner for firms navigating the rigorous regulatory landscape. Their expertise in topical product development allows them to streamline the transition from early-stage research to commercial-ready drug products, effectively reducing time-to-market for their partners.
How much funding has Dow Development Laboratories raised?
Dow Development Laboratories has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Dow Development Laboratories
PPP
Public-Private Partnership
What's next for Dow Development Laboratories?
With the successful acquisition of this latest financing, Dow Development Laboratories is poised to scale its infrastructure and enhance its technical service offerings. The strategic deployment of this capital will likely focus on expanding laboratory capacity and refining analytical methodologies to meet the increasing demand for specialized topical drug delivery systems. As the company moves deeper into its late-stage lifecycle, the focus will shift toward optimizing operational efficiencies and strengthening its regulatory compliance framework to support larger-scale clinical trials and commercial manufacturing mandates. This growth trajectory positions the firm to capture a larger share of the outsourced pharmaceutical development market, leveraging its established reputation for quality and proactive client engagement.
See full Dow Development Laboratories company page
